Is BAP a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Credicorp (BAP) rests on Yape turning from a payments app into a lender: Yape's ~16 million monthly active users make it the default way Peruvians move money, and BCP has been converting that base into credit: over 4.1 million clients have taken loans through it. The bear case rests on peruvian political risk is the dominant variable and it is not hypothetical: two presidents were removed between October 2025 and February 2026, and the April 2026 general election produced a fragmented result with a contested count and calls for annulment. Analysts covering it publish targets from $219.00 to $482.00 against a $352.97 price, so even the professionals disagree by 62% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Credicorp is a Bermuda-incorporated holding company headquartered in Lima that owns Peru's largest bank and most of the country's financial plumbing. It runs four lines of business: Universal Banking through Banco de Crédito del Perú (BCP) and Banco de Crédito de Bolivia; Microfinance through Mibanco in Peru and Colombia; Insurance and Pensions through Grupo Pacífico and the private pension manager Prima AFP; and Investment Management and Advisory through Credicorp Capital, BCP's wealth management arm and ASB Bank Corp. The group's most interesting asset is not a balance sheet line at all: Yape, BCP's payments wallet, reached roughly 16 million monthly active users and has extended credit to over 4.1 million clients, and now contributes about 8% of group risk-adjusted revenue. In May 2026 Peru's banking regulator (the SBS) cleared BCP to acquire 100% of Helm Bank USA, adding a Miami-based dollar banking footprint for Latin American clients. The investment picture is a quality-versus-country trade. Credicorp earns bank returns that most developed-market lenders cannot: first-quarter 2026 net income was a record ~S/2.06 billion, up ~16% year over year, with ROE of ~21.1%, and management has guided to closing 2026 with ROE near ~19.5%. Fitch upgraded the group to BBB+ in June 2026, placing it one notch above Peru's own sovereign rating, which is an unusual thing for a bank to achieve. Second-quarter 2026 EPS of about $7.38 was essentially in line with the ~$7.36 consensus, and trailing net income has reached about S/7.4 billion. Against that, the shares trade at roughly ~14.7x trailing and ~11.4x forward earnings with a ~3.7% dividend yield, because Peru removed two presidents between October 2025 and February 2026 and the April 2026 general election produced a fragmented, contested result. The stock has already re-rated hard (up from a ~$230 low to a ~$413 high over the past year, and closing at about $391 on October 16, 2026, up ~37% year to date), so the easy discount has narrowed while the political overhang has not gone away. JPMorgan upgraded the shares to overweight in September 2026 with a $482 target. Third-quarter results are due November 9, 2026 (consensus EPS ~$7.49), followed by a 2026 strategic update on November 17.

The bull case: what would have to be true for $482.00

The most optimistic published target on BAP is $482.00, +36.6% from the $352.97 price as of November 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Yape turning from a payments app into a lender

Yape's ~16 million monthly active users make it the default way Peruvians move money, and BCP has been converting that base into credit: over 4.1 million clients have taken loans through it. Because acquisition and servicing costs are near zero relative to a branch, the incremental revenue lands at high margin, which is why other core income grew ~19.5% year over year in the first quarter of 2026. Yape at ~8% of risk-adjusted revenue is the clearest path to structurally higher group returns.

2. Retail loan mix shifting margins upward

Loan growth of ~8.2% year over year in the first quarter of 2026 was skewed toward retail and microfinance, which carry wider spreads than corporate lending. Deposits grew faster still, at ~13.3%, which funds that mix cheaply. Management's ~19.5% full-year 2026 ROE guidance leans on this combination of a richer asset mix and a controlled cost of risk rather than on volume alone. Group revenue growth of about 12% year over year in the latest quarter shows the mix shift is still carrying the top line, and the November 17, 2026 strategic update is where management is expected to set the next set of targets.

3. Credit costs normalising after the 2023-2024 stress

Peru's 2023 recession and the El Niño shock drove provisions sharply higher, particularly at Mibanco, and the recovery in earnings since then is substantially a provisioning story. Asset quality improvement was explicitly cited in Fitch's June 2026 upgrade to BBB+. Further normalisation flatters reported earnings without requiring any new business to be written.

4. Dollar and regional expansion via Helm Bank USA

The SBS authorised BCP to buy 100% of Helm Bank USA on May 5, 2026, giving Credicorp a US-regulated dollar banking platform for Latin American wealth clients. It diversifies revenue away from the sol and pairs with Credicorp Capital and ASB Bank Corp in fee income. The amounts are small next to a ~$31 billion market cap, but the direction reduces single-country dependence.

The bear case: what would have to be true for $219.00

The most pessimistic published target is $219.00, -38.0% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Credicorp is worth if the risks below bite instead of the drivers above.

Peruvian political risk is the dominant variable and it is not hypothetical: two presidents were removed between October 2025 and February 2026, and the April 2026 general election produced a fragmented result with a contested count and calls for annulment. Congress has now authorised eight pension withdrawals since 2019, shrinking private pension assets from roughly $52 billion to around $22 billion, which directly erodes the Prima AFP business and signals that financial-sector rules can be rewritten quickly. Because Credicorp reports in Peruvian soles, a US holder's returns can be cut by currency depreciation even when the bank performs well. The concentration in one small economy also means a commodity downturn (copper prices), a weather shock or renewed social unrest around illegal mining feeds straight into loan losses, and OECD and IMF work through 2026 flags exactly those channels alongside GDP growth of only about 3%. Finally, the shares have already moved from a ~$230 low toward a ~$413 high and sat near $391 on October 16, 2026, so a re-rating that assumed political calm has limited room left if that assumption breaks.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding BAP already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on BAP

14 analysts cover BAP, with an average target of $427.48 (+21.1% against $352.97) and a split of 12 buy, 2 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the BAP forecast and price target page.

How is BAP valued? (as of October 2026)

Price
$352.97
Market cap
$28.03B
P/E (TTM)
13.29
Forward P/E
10.31
Price / book
2.61
Beta
0.82
52-week range
$230.45 to $413.25

Snapshot for BAP as of November 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Share price: ~$391 (Oct 16, 2026)
  • Market cap: ~$31.0B
  • Revenue (TTM): ~S/22.3B (FY2025 ~$6.8B); latest quarter up ~12% YoY
  • Net income (TTM): ~S/7.4B (FY2025 ~$2.06B)
  • EPS (Q2 2026): ~$7.38 vs ~$7.36 consensus
  • P/E (trailing / forward): ~14.7x / ~11.4x
  • Dividend yield: ~3.7% (~$14.41 per share)
  • Analyst sentiment: 14 analysts, consensus buy, mean target ~$427

Trailing EPS of ~$26.55 is already elevated, so the ~14.7x multiple is being paid on high earnings rather than a depressed base; the forward multiple falls to ~11.4x on 2027 consensus EPS of ~$34.24. Q2 2026 came in essentially on estimate after a Q1 beat, and the next print (3Q26) is scheduled for November 9, 2026 with consensus near $7.49, followed by a strategic update on November 17. The ~3.7% yield is the part of the return that does not depend on the multiple holding.

How do you decide if BAP is a buy?

Whether BAP is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold BAP indirectly through an index or sector ETF before adding more.

What would change your mind on BAP

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Yape turning from a payments app into a lender stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: peruvian political risk is the dominant variable and it is not hypothetical: two presidents were removed between October 2025 and February 2026, and the April 2026 general election produced a fragmented result with a contested count and calls for annulment fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the BAP stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about BAP against your real portfolio and see your actual exposure before deciding.

Investing in Credicorp with AI

Connect the broker you already use and ask Walnut's AI how BAP fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is BAP a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Yape turning from a payments app into a lender, with revenue (ttm) at ~S/22.3B (FY2025 ~$6.8B); latest quarter up ~12% YoY. The bear case rests on peruvian political risk is the dominant variable and it is not hypothetical: two presidents were removed between October 2025 and February 2026, and the April 2026 general election produced a fragmented result with a contested count and calls for annulment. Analysts covering it are spread from $219.00 to $482.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell BAP?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Peruvian political risk is the dominant variable and it is not hypothetical: two presidents were removed between October 2025 and February 2026, and the April 2026 general election produced a fragmented result with a contested count and calls for annulment. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $219.00, -38.0% from the $352.97 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for BAP?

+

Yape turning from a payments app into a lender. Yape's ~16 million monthly active users make it the default way Peruvians move money, and BCP has been converting that base into credit: over 4.1 million clients have taken loans through it. The most optimistic analyst target on BAP is $482.00, +36.6% from the $352.97 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for BAP?

+

Peruvian political risk is the dominant variable and it is not hypothetical: two presidents were removed between October 2025 and February 2026, and the April 2026 general election produced a fragmented result with a contested count and calls for annulment. Congress has now authorised eight pension withdrawals since 2019, shrinking private pension assets from roughly $52 billion to around $22 billion, which directly erodes the Prima AFP business and signals that financial-sector rules can be rewritten quickly. Because Credicorp reports in Peruvian soles, a US holder's returns can be cut by currency depreciation even when the bank performs well. The concentration in one small economy also means a commodity downturn (copper prices), a weather shock or renewed social unrest around illegal mining feeds straight into loan losses, and OECD and IMF work through 2026 flags exactly those channels alongside GDP growth of only about 3%. Finally, the shares have already moved from a ~$230 low toward a ~$413 high and sat near $391 on October 16, 2026, so a re-rating that assumed political calm has limited room left if that assumption breaks. The most pessimistic published target is $219.00, -38.0% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does Credicorp do?

+

Peru's largest financial group, owning Banco de Credito del Peru, Mibanco, Grupo Pacifico, Prima AFP and Credicorp Capital.

What would have to change for BAP to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Yape turning from a payments app into a lender) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (peruvian political risk is the dominant variable and it is not hypothetical: two presidents were removed between October 2025 and February 2026, and the April 2026 general election produced a fragmented result with a contested count and calls for annulment) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What is BAP stock?

+

BAP is the NYSE ticker for Credicorp Ltd., Peru's largest financial group. It owns Banco de Crédito del Perú, the microfinance lender Mibanco, insurer Grupo Pacífico, pension manager Prima AFP and Credicorp Capital, and it reports results in Peruvian soles.

Is BAP an ADR?

+

No. Credicorp is incorporated in Bermuda and its common shares list directly on the NYSE, so there is no depositary bank or ADR fee layer. The practical exposure is still foreign: the business, the reporting currency (the sol) and the regulator are all Peruvian.

Does BAP pay a dividend?

+

Yes. The trailing dividend is about $14.41 per share, a yield near 3.7% as of October 16, 2026, and roughly 54% of trailing earnings. Credicorp pays from Peruvian earnings, so the dollar amount a US holder receives moves with the sol as well as with the payout decision.

Walnut is informational, not investment advice, and gives no verdict on BAP. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

The case for and against similar stocks